On ECHEMI
Home > Drugs > Obstructive emphysema
Obstructive emphysema
Obstructive pulmonary emphysema is a disease characterized by persistent expansion and dilation of the distal air sac cavity of the terminal bronchioles (including respiratory bronchioles, alveolar ducts, alveolar sacs and alveoli), accompanied by destruction of the air cavity wall structure without obvious fibrosis. This disease is often caused by chronic bronchitis induced by long-term smoking, air pollution, inhalation of harmful chemicals and dust, and chronic recurrent respiratory tract infections, which further develop into this disease.
  • Site of disease:

    lung
  • Infectious :

    Not contagious
  • Frequent population:

    Smokers and chronic bronchitis patients
  • Related symptoms:

    Barrel chest Chest tightness Dyspnea on exertion Decreased breath sounds Shortness of breath
  • Concurrent disease:

Related Drugs
Aminophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:

Harbin Taihua Pharmaceutical Co., Ltd.

Aminophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Aminophylline sustained-release tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:

Yabao Pharmaceutical Group Co., Ltd.

Aminophylline
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Aminophylline
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Manufacturer:

Shandong Xinhua Pharmaceutical Company Limited

Theophylline Sodium Glycine Tablets
Indication: It is suitable for relieving wheezing symptoms of bronchial asthma, asthmatic bronchitis, obstructive pulmonary emphysema, etc.; it can also be used for asthma caused by cardiogenic pulmonary edema.
Bambuterol Hydrochloride Tablets
Indication: Used for bronchial asthma, chronic asthmatic bronchitis, obstructive pulmonary emphysema and other lung diseases accompanied by bronchospasm.
Manufacturer:

Nanjing Haijing Pharmaceutical Co., Ltd.

Emphysema tablets
Manufacturer:

Guangdong Wanfang Pharmaceutical Co., Ltd.

Emphysema tablets
Manufacturer:

Shanxi Deyuantang Pharmaceutical Co., Ltd.

Emphysema tablets
Manufacturer:

Jiangsu 707 Natural Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.